根據最新的財務報表(Form-10K),Invitro International 的總資產為 $0,淨損失為 $0
IVRO 的關鍵財務比率是什麼?
Invitro International 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Invitro International 的收入按細分市場或地理位置如何劃分?
Invitro International 最大收入來源為 In-vitro (Non-animal) Consumer, Product, and Environmental Safety Test Method,在最近的收益報告中收入為 878,937。就地區而言,United States 是 Invitro International 的主要市場,收入為 520,705。
Invitro International 是否盈利?
無,根據最新的財務報表,Invitro International 的淨損失為 $0
Invitro International 有負債嗎?
無,Invitro International 的負債為 0
Invitro International 的流通股有多少?
Invitro International 的總流通股為 0
關鍵數據
前收市價
$0.0853
開盤價
$0.07
當日範圍
$0.0556 - $0.0853
52週區間
$0.0315 - $0.16
交易量
28.4K
平均成交量
44.7K
股息收益率
--
每股盈餘 (TTM)
0.00
市值
$1.8M
什麼是 IVRO?
InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.